A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users

Trial Profile

A Study to Evaluate the Abuse Potential of EB-1020 Immediate-Release in Healthy Recreational Stimulant Users

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Mar 2015

At a glance

  • Drugs Centanafadine (Primary) ; Dexamfetamine; Lisdexamfetamine
  • Indications Attention-deficit hyperactivity disorder
  • Focus Pharmacodynamics
  • Sponsors Neurovance
  • Most Recent Events

    • 13 Aug 2014 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 16 Jun 2014 Status changed from planning to recruiting; according to ClinicalTrials.gov record.
    • 07 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top